Friday, November 27, 2015

Daniel Hoffman

How much to cut drug prices?

Monday, August 31, 2015, 5:30 AM
On August 20, the Kaiser Family Foundation published the latest results from its poll that tracks health care opinions among American consumers. The pollsters found that only slightly more than four in 10 respondents (42 percent) have a positive view of pharma companies. That ranks the pharma industry... Read more

Proposals to make drug pricing more transparent

Monday, August 24, 2015, 5:30 AM
Americans are starting to feel the pinch from high drug prices. In a survey recently reported by Consumer Reports, one-third of Americans said they paid an average of $39 above the usual cost for their latest prescription. One in ten said they paid $100 or more out-of-pocket. Forty per cent of people... Read more

Follow Up: Tips to cut your prescription costs

Monday, August 17, 2015, 12:40 PM
After an excerpt from last week's post appeared in the Inquirer's Sunday print edition, a number of people called and wrote to ask where they could find a Canadian pharmacy to save some money on prescriptions. I told them that as someone who is not a health care practitioner, I cannot recommend any... Read more

7 tips to cut your prescription costs

Monday, August 10, 2015, 12:26 PM
Last year the U.S. sustained the biggest increase in prescription drug spending since 2003, according to a report published this spring by pharmacy benefit manager, Express Scripts. Hefty increases in drug costs are likely to continue as pharma prepares to launch new drug classes such as PCSK-9's... Read more

Pharma stiffs suppliers on invoice payment times: accounting or crime?

Monday, August 3, 2015, 9:20 AM
Any supplier of services to the pharmaceutical industry is acutely aware that the drug companies now take far longer to pay invoices. In many other ways, pharma's onerous payment terms have imposed serious burdens on those vastly smaller suppliers. This seemingly humdrum matter of invoice payment policy... Read more

Pharma distorts the facts to keep Medicare from negotiating drug prices

Monday, July 27, 2015, 10:40 AM
In 1967, Richard S. Harris wrote a four-part series for The New Yorker, describing how Medicare came to be enacted. The leading opponent of that legislation was the American Medical Association. The AMA's central argument against this valuable piece of legislation was its contention that government-supported... Read more

Pharma Weakens FDA Oversight as the Price of Letting Congress Increase NIH Funding

Monday, July 13, 2015, 3:03 PM
Last Friday, July 10, the United States House of Representatives passed H.R. 6 by a vote of 344-77. Pennsylvania Congressmen Barletta, Boyle, Brady, Cartwright, Costello, Dent, Doyle, Fattah, Kelly, Marino, Meehan, Murphy, Pitts, Rothfus, Shuster, and Thompson all supported its passage. The bill, known... Read more

Pharma's specialty drug pricing can torpedo US health care

Thursday, July 2, 2015, 3:39 PM
This past February CVS/Caremark issued a report that forecast a new class of cholesterol drugs, the PCSK-9’s, will cost the U.S. health care system as much as $150 billion a year. Some observers dispute the size of that projected cost, but at the same time the pharma companies are also preparing... Read more

Why pharma can't adapt to the changing health environment

Wednesday, June 24, 2015, 12:48 PM
In nearly every sector of health care, competing companies are acting aggressively to position themselves for prospering in a rapidly changing environment. Consider first the provider segment. Hospital-based systems are gobbling up physician practices to the point where investment bank Credit Suisse... Read more

Trans-Pacific Partnership: Pharma's payoff for Obamacare neutrality

Wednesday, June 17, 2015, 11:08 AM
In 1993 the new Clinton administration decided to make health care reform the signature issue of its first term. Bill Clinton appointed his wife to pilot the initiative, but the entire effort was botched from the get-go. Dubbed Hillarycare by the media, the package was an unwieldy piece of Rube Goldberg... Read more
About this blog

Check Up is a blog for savvy health consumers, covering the latest developments, discoveries, and debates from the Philadelphia area and beyond.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Charlotte Sutton Health and Science Editor, Philadelphia Inquirer
Tom Avril Inquirer Staff Writer, heart health and general science
Stacey Burling Inquirer Staff Writer, neuroscience and aging
Marie McCullough Inquirer Staff Writer, cancer and women's health
Don Sapatkin Inquirer Staff Writer, public health, infectious diseases and substance abuse
Justin D'Ancona
David Becker, M.D. Board certified cardiologist, Chestnut Hill Temple Cardiology
Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Hooman Noorchashm, M.D., Ph.D. Cardiothoracic surgeon in the Philadelphia area
Amy J. Reed, M.D., Ph.D. Anesthesiologist and Surgical Intensivist in the Philadelphia Area
Latest Health Videos
Also on
letter icon Newsletter